Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5?-deoxy-5-fluorouridine-Reference-Cited by-同舟云学术

Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5?-deoxy-5-fluorouridine

Published:1993 Issue:5 Volume:32 Page:333-338
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Eda Hiroyuki,Fujimoto Kaori,Watanabe Shin-ichi,Ura Masako,Hino Ayako,Tanaka Yutaka,Wada Kenji,Ishitsuka Hideo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00735915.pdf

Reference31 articles.

1. Arbuck SG (1989) Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer 63: 1036

2. Armstrong RD, Cadman E (1983) 5?-Deoxy-5-fluorouridine selective toxicity for human cells compared to human bone marrow. Cancer Res 43: 2525

3. Beutler B, Cerami A (1985) Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells. J Immunol 135: 3969

4. Bollag E, Hartmann HR (1980) Tumor inhibiting effects of a new fluorouracil derivative 5?-deoxy-5-fluorouridine. Eur J Cancer 16: 427

5. Bruckner HW, Storch JA, Holland JF (1981) Leucovorin increases the toxicity of 5-fluorouracil: phase I clinical pharmacological trials. Proc Am Assoc Cancer Res/Am Soc Clin Oncol 22: 192

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vesicular IFN-γ as a cooperative attacker to enhance anti-cancer effect of 5-fluorouracil via thymidine phosphorylase upregulation and tumor microenvironment normalization;Nanomedicine: Nanotechnology, Biology and Medicine;2022-02

2. 18F-FLT PET/CT as a prognostic imaging biomarker of disease specific survival in patients with primary soft tissue sarcoma;Journal of Nuclear Medicine;2021-09-30

3. Recent Strategies to Develop Innovative Photosensitizers for Enhanced Photodynamic Therapy;Chemical Reviews;2021-09-28

4. Non-Coding Micro RNAs and Hypoxia-Inducible Factors Are Selenium Targets for Development of a Mechanism-Based Combination Strategy in Clear-Cell Renal Cell Carcinoma—Bench-to-Bedside Therapy;International Journal of Molecular Sciences;2018-10-29

5. Thymidine phosphorylase: A potential new target for treating cardiovascular disease;Trends in Cardiovascular Medicine;2018-04